Business · 15/12/2015
FDA Releases Leapfrog Guidance for Implantable MIGS Devices
The FDA has made available a new guidance document outlining the recommended non-clinical and clinical studies needed to support a premarket approval application for implantable minimally invasive glaucoma surgical devices, also known as MIGS devices.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →